nav-left cat-right
cat-right

Green protein inhibits Alheimer’s, CSIRO sci...

BY NYSSA SKILTON MEDICAL REPORTER 18/11/2008 CSIRO scientists have developed a way to screen for compounds that can inhibit the progression of Alzheimer’s disease. The system involves using live yeast and a protein called Abeta fused to a fluorescent green protein, which comes from jellyfish. The scientists, working within CSIRO’s Preventive Health Flagship, published their findings in the latest edition of...

Scientists seek out Alzheimer’s enemies

CSIRO scientists have developed a new system to screen for compounds that can inhibit one of the processes that takes place during the progression of Alzheimer’s disease. In a paper published in the Journal of Alzheimer’s Disease, folate is shown to be beneficial in the screening system. Lead author, CSIRO’s Dr Ian Macreadie says folate is already well known to have a protective effect against...

The increased sensitivity, functionality and vehic...

Syft Technologies is launching the next generation of Sift-MS instrumentation, the Voice200, which it says delivers real-time identification and quantitation of volatile organic compounds (VOCs) at the push of a button. Geoff Peck CEO of Syft Technologies says: ‘The design criteria and market requirements for this next generation of instruments were exacting. ‘We set a goal to significantly reduce the size and...

Cytopia Announces Major License and R&D Colla...

MELBOURNE, Australia, June 4 /PRNewswire-FirstCall/ — Cytopia Ltd (ASX: CYT – News) today announced the signing of a global license and research and development collaboration with Novartis to develop orally active, small molecule therapeutics targeting JAK3 kinase for the prevention of transplant rejection and the treatment of multiple indications in autoimmune diseases such as rheumatoid arthritis. Both companies...

egoli Biotech & Health News: AEI, EPT, NDL, S...

(AEI) AERIS TECHNOLOGIES LTD –3.0c to 77.0c; Advises that in conjunction with the University of New South Wales, it has been awarded a $540,000 Australian Research Council ARC Linkage Grant. The grant covers a period of 3 years from July 2005 and will fund research into substantially broadening the Aeris enzyme applications and product portfolio. This new range of enhanced enzymes is to be achieved through chemical...

Software that automatically assesses a drug’...

Potential new drugs for neurological disorders like Parkinson’s are being screened faster thanks to world-leading CSIRO software that automatically assesses a drug’s effect on nerve cells. The image analysis software will be highlighted at BIO2005, the world’s largest biotechnology conference, on 19-22 June in Philadelphia, USA. In the search for new pharmaceuticals, thousands of chemical compounds are...